If you've been told that hip replacement is your only option, you may want to know that the latest research is changing that conversation. Hip replacement remains one of the most common surgeries in the United States, with more than 544,000 procedures performed every year. For many people living with hip osteoarthritis, surgery has long been presented as the inevitable next step once joint damage progresses.

However, new peer-reviewed research suggests that this may not always be true. A landmark 15-year study found that properly selected patients who received intraosseous bone marrow concentrate had a significantly lower chance of needing hip replacement compared to those who received conservative care alone. The findings highlight the importance of early evaluation and may offer another treatment option before surgery becomes necessary.

Episode Video

What the New 15-Year Study Found About Hip Osteoarthritis

The study followed 434 hips over a period of 15 years. Researchers compared patients who received bone marrow concentrate injections directly into the femoral head with similar patients who received standard conservative care. Both groups were carefully matched by age, sex, arthritis severity, and the cause of their hip osteoarthritis.

The results were remarkable. After 15 years, only 16.1% of patients treated with intraosseous bone marrow concentrate required total hip replacement. In comparison, 40.1% of patients receiving conservative care eventually underwent surgery. This represents a substantial reduction in the likelihood of needing hip replacement over time.

The difference became more noticeable as the years passed. At five years, only 4.6% of treated hips progressed to hip replacement compared with 28.6% in the conservative care group. At ten years, the treatment group reached 12%, while the conservative care group increased to 35.9%. These long-term results suggest that the biological effect remained durable throughout the study.

Why Bone Marrow Concentrate May Help Delay Hip Replacement

Bone marrow concentrate uses your body's own biological cells. In this study, doctors delivered the concentrate directly into the bone beneath the hip joint surface, an approach known as an intraosseous injection.

Researchers also discovered an important dose-response relationship. Patients who received higher concentrations of stem cell-rich bone marrow concentrate experienced the best outcomes. The highest-dose group had only a 1.4% conversion to hip replacement after 15 years. This finding strengthens the evidence that the treatment's benefits are based on biological activity rather than chance.

Who May Be a Good Candidate for Bone Marrow Concentrate?

The research suggests that the best candidates share several important characteristics. Patients with early to moderate hip osteoarthritis, minimal structural joint damage, and no significant hip dysplasia demonstrated the strongest outcomes.

On the other hand, patients with severe osteoarthritis, advanced structural changes, or hip dysplasia responded less favorably. In these situations, a physician may determine that hip replacement remains the most appropriate treatment option.

The key message is not that every patient should avoid surgery. Instead, it is that you deserve an evaluation early enough to understand all available treatment options before your condition progresses beyond the point where biological therapies may be effective.

Why Early Treatment for Hip Osteoarthritis Matters

Timing proved to be one of the most important factors in the study. Patients with mild to moderate hip osteoarthritis experienced the greatest benefit from treatment. Once the disease progressed to advanced stages or significant structural changes developed, the effectiveness of biological treatment became much more limited.

Hip osteoarthritis often progresses quietly. Unlike knee arthritis, hip pain may be easier to ignore, causing many people to delay seeking medical evaluation. Unfortunately, waiting too long may reduce your treatment options.

If imaging shows that your arthritis is still in its early or moderate stages, you may still be within the window where biological treatment could meaningfully delay the need for surgery. As the disease advances, that opportunity may become much smaller.

The Link Between Corticosteroids and Hip Damage

The discussion extends beyond osteoarthritis alone. Previous research has shown that long-term corticosteroid exposure can increase the risk of osteonecrosis of the femoral head, a condition in which bone tissue loses its blood supply and begins to collapse.

A large study published in 2024 demonstrated that early treatment with intraosseous bone marrow concentrate may support bone repair before collapse occurs. If you have a history of long-term corticosteroid use and begin experiencing groin pain or hip pain, early imaging and evaluation by a physician are especially important. Detecting the problem before significant bone damage develops may preserve more treatment options.

What This Research Means for Your Treatment Decisions

This study does not suggest that biological treatment replaces hip replacement for everyone. Instead, it provides strong evidence that properly dosed intraosseous bone marrow concentrate may significantly delay surgery in carefully selected patients with early to moderate hip osteoarthritis.

If your arthritis has already reached an advanced stage or major structural changes are present, surgery may still offer the best outcome. An experienced physician should evaluate your imaging, symptoms, and overall joint health to determine whether biological treatment or hip replacement is the most appropriate path.

The most important takeaway is that timing matters. Waiting until hip osteoarthritis becomes severe may limit your treatment choices. Seeking an evaluation earlier allows you to understand whether you remain a candidate for treatments that could delay or potentially avoid hip replacement.

Final Thoughts

If you've been told that hip replacement is inevitable, this new long-term research encourages you to ask additional questions before making your decision. Early evaluation can determine whether your hip osteoarthritis is still at a stage where biological treatment may provide meaningful benefit.

Current evidence supports the idea that patients with early to moderate disease who receive appropriately dosed intraosseous bone marrow concentrate may significantly reduce their likelihood of requiring hip replacement over the long term. While surgery remains an important option for advanced disease, acting early may help preserve your joint, expand your treatment options, and potentially delay the need for a total hip replacement.

Frequently Asked Questions

1. Can I delay hip replacement if I have hip osteoarthritis?
   If you have early to moderate hip osteoarthritis, research suggests that intraosseous bone marrow concentrate may help delay hip replacement in the right patients. The best way to know if you're a candidate is to have your hip evaluated by a physician before the arthritis becomes advanced.

2. Am I a good candidate for bone marrow concentrate treatment?
   You may be a good candidate if you have mild to moderate hip osteoarthritis without significant structural changes, such as severe hip dysplasia. A physician can determine your candidacy based on your symptoms, imaging, and overall joint condition.

3. Should I wait until my hip pain gets worse before seeking treatment?
   Waiting may reduce your treatment options because hip osteoarthritis can continue to progress over time. Early evaluation gives you the best opportunity to explore treatments that may help delay hip replacement.

4. Can bone marrow concentrate replace hip replacement surgery for me?
   Bone marrow concentrate is not a replacement for hip replacement in every case, especially if you have advanced osteoarthritis or major structural damage. Your physician can help determine whether biological treatment or surgery is the better option for your condition.

5. Should I be concerned if I've used corticosteroids and now have hip pain?
   Yes, long-term corticosteroid use can increase the risk of osteonecrosis of the femoral head, which can lead to serious hip damage if left untreated. If you're experiencing hip or groin pain, it's important to seek an evaluation and imaging as early as possible.

If you're ready to take control of your knee pain, click here to discover more about these five effective knee pain home treatments. With these simple steps, you can start your journey towards pain-free knees and a more active lifestyle.